Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants; A lesson for replication studies

Diabetes

Volumn 57, Issue 11, 2008, Pages 3161-3165

  Barroso, Inês ^a   Luan, JiaN'An ^b   Wheeler, Eleanor ^a   Whittaker, Pamela ^a   Wasson, Jon ^c   Zeggini, Eleftheria ^d,e   Weedon, Michael N ^f   Hunt, Sarah ^a   Venkatesh, Ranganath ^a   Frayling, Timothy M ^f   Delgado, Marcos ^a,d   Neuman, Rosalind J ^c   Zhao, Jinghua ^b   Sherva, Richard ^c   Glaser, Benjamin ^d,g   Walker, Mark ^h   Hitman, Graham ⁱ   McCarthy, Mark I ^d,e   Hattersley, Andrew T ^f   Permutt, M Alan ⁱ   Wareham, Nicholas J ^b   Deloukas, Panagiotis ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f PENINSULA MEDICAL SCHOOL   (United Kingdom)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4;

ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; CAUCASIAN; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; JEW; RISK; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; JEWS; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 57649190746     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0719     Document Type: Article

References (27)

1. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, Jackson AU, Deloukas P, Hunt S, Stavrides G, Chines PS, Erdos MR, Narisu N, Conneely KN, Li C, Fingerlin TE, Dhanjal SK, Valle TT, Bergman RN, Tuomilehto J, Watanabe RM, Boehnke M, Collins FS: Genetic variation near the hepatocyte nuclear factor-4α gene predicts susceptibility to type 2 diabetes. Diabetes 53:1141-1149, 2004
2. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, Permutt MA: A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4α gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53:1134-1140, 2004
3. Damcott CM, Hoppman N, Ott SH, Reinhart LJ, Wang J, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR: Polymorphisms in both promoters of hepatocyte nuclear factor 4-α are associated with type 2 diabetes in the Amish. Diabetes 53:3337-3341, 2004
4. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, McCarthy MI, Love-Gregory LD, Permutt MA, Hattersley AT, Frayling TM: Common variants of the hepatocyte nuclear factor-4α P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 53:3002-3006, 2004
5. Hansen SK, Rose CS, Glumer C, Drivsholm T, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T: Variation near the hepatocyte nuclear factor (HNF)-4α gene associates with type 2 diabetes in the Danish population. Diabetologia 48:452-458, 2005
6. Lehman DM, Richardson DK, Jenkinson CP, Hunt KJ, Dyer TD, Leach RJ, Arya R, Abboud HE, Blangero J, Duggirala R, Stern MP: P2 Promoter variants of the hepatocyte nuclear factor 4α gene are associated with type 2 diabetes in mexican americans. Diabetes 56:513-517, 2007
7. Bonnycastle LL, Willer CJ, Conneely KN, Jackson AU, Burrill CP, Wa- tanabe RM, Chines PS, Narisu N, Scott LJ, Enloe ST, Swift AJ, Duren WL, Stringham HM, Erdos MR, Riebow NL, Buchanan TA, Valle TT, Tuomilehto J, Bergman RN, Mohlke KL, Boehnke M, Collins FS: Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55:2534-2540, 2006
8. Vaxillaire M, Dina C, Lobbens S, Dechaume A, Vasseur-Delannoy V, Helbecque N, Charpentier G, Froguel P: Effect of common polymorphisms in the HNF4α promoter on susceptibility to type 2 diabetes in the French Caucasian population. Diabetologia 48:440-444, 2005
9. Winckler W, Graham RR, de Bakker PI, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Groop L, Altshuler D: Association testing of variants in the hepatocyte nuclear factor 4α gene with risk of type 2 diabetes in 7,883 people. Diabetes 54:886-892, 2005
10. Bagwell AM, Bento JL, Mychaleckyj JC, Freedman BI, Langefeld CD, Bowden DW: Genetic analysis of HNF4α polymorphisms in Caucasian- American type 2 diabetes. Diabetes 54:1185-1190, 2005
11. Tanahashi T, Osabe D, Nomura K, Shinohara S, Kato H, Ichiishi E, Nakamura N, Yoshikawa T, Takata Y, Miyamoto T, Shiota H, Keshavarz P, Yamaguchi Y, Kunika K, Moritani M, Inoue H, Itakura M: Association study on chromosome 20q11.21-13.13 locus and its contribution to type 2 diabetes susceptibility in Japanese. Hum Genet 120:527-542, 2006
12. Wanic K, Malecki MT, Wolkow PP, Klupa T, Skupien J, Bobrek J, Kozek E, Krolewski AS, Sieradzki J: Polymorphisms in the gene encoding hepato-cyte nuclear factor-4α and susceptibility to type 2 diabetes in a Polish population. Diabet Metab 32:86 -88, 2006
13. Muller YL, Infante AM, Hanson RL, Love-Gregory L, Knowler W, Bogardus C, Baier LJ: Variants in hepatocyte nuclear factor 4α are modestly associated with type 2 diabetes in Pima Indians. Diabetes 54:3035-3039, 2005
14. Hara K, Horikoshi M, Kitazato H, Ito C, Noda M, Ohashi J, Froguel P, Tokunaga K, Tobe K, Nagai R, Kadowaki T: Hepatocyte nuclear factor-4α P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population. Diabetes 55:1260-1264, 2006
15. Ek J, Hansen SP, Lajer M, Nicot C, Boesgaard TW, Pruhova S, Johansen A, Albrechtsen A, Yderstraede K, Lauenborg J, Parrizas M, Boj SF, Jorgensen T, Borch-Johnsen K, Damm P, Ferrer J, Lebl J, Pedersen O, Hansen T: A novel -192c/g Mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4α gene (HNF4α) associates with late-onset diabetes. Diabetes 55:1869-1873, 2006
16. Johansson S, Raeder H, Eide SA, Midthjell K, Hveem K, Sovik O, Molven A, Njolstad PR: Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4α (HNF4α) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes 56:3112-3117, 2007
17. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O'Rahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Bottazzo GF, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, McCarthy MI: A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am, J Hum, Genet 69:553-569, 2001
18. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1:E20, 2003
19. Harding AH, Day NE, Khaw KT, Bingham S, Luben R, Welsh A, Wareham NJ: Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of cancer-Norfolk study. Am J Epidemiol 159:73-82, 2004
20. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N:EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 Suppl 1:95-103, 1999
21. Owen KR, Roland J, Smith K, Hattersley AT: Adolescent onset type 2 diabetes in a non-obese Caucasian patient with an unbalanced translocation. Diabet Med 20:483-485, 2003
22. Mitchell SM, Weedon MN, Owen KR, Shields B, Wilkins-Wall B, Walker M, McCarthy MI, Frayling TM, Hattersley AT: Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. subjects. Diabetes 52:1276-1279, 2003
23. Weedon MN, Turner M, Knight B, Clark P, Hattersley AT, Frayling TM: Variants in the aromatase gene and on the Y-chromosome are not associated with adult height or insulin resistance in a UK population. Clin Endocrinol (Oxf) 59:175-179, 2003
24. Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, Glaser B: A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50:681-685, 2001
25. Ke X, Hunt S, Tapper W, Lawrence R, Stavrides G, Ghori J, Whittaker P, Collins A, Morris AP, Bentley D, Cardon LR, Deloukas P: The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet 13:577-588, 2004
26. Spencer CCA, Deloukas P, Hunt S, Mullikin J, Myers S, Silverman B, Donnelly P, Bentley D, McVean G: The influence of recombination on human genetic diversity. PLoS Genetics 2: e148, 2006
27. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, Gunderson KL, Hansen M, Steemers F, Butler SL, Deloukas P, Galver L, Hunt S, McBride C, Bibikova M, Rubano T, Chen J, Wickham E, Doucet D, Chang W, Campbell D, Zhang B, Kruglyak S, Bentley D, Haas J, Rigault P, Zhou L, Stuelpnagel J, Chee MS: Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 68:69-78, 2003